Table 1.
Baseline characteristics by arms of the study
| Sputnik V C1 cohort (n = 669) | ||||||
|---|---|---|---|---|---|---|
| Sputnik V C2 | Sputnik V C1 | Ad5-nCoV | ChAdOx1-S | BBIBP-CorV | mRNA-1273 | |
| Participants, n | 103 | 69 | 50 | 142 | 157 | 148 |
| Age, years, mean (SD) | 45 (11) | 41 (10) | 49 (12) | 46 (12) | 43 (11) | 49 (12) |
| Gender, n (%) | ||||||
| Female | 49 (48) | 36 (52) | 31 (66) | 60 (42) | 72 (46) | 78 (53) |
| Male | 54 (52) | 33 (48) | 16 (34) | 82 (58) | 85 (54) | 70 (47) |
| Comorbidities, n (%) | ||||||
| Diabetes | 4 (3.9) | 3 (4.3) | 0 (0) | 5 (3.5) | 12 (7.6) | 7 (4.7) |
| Obesity | 13 (12.6) | 9 (13.0) | 1 (2.6) | 19 (13.4) | 26 (1.6) | 10 (6.8) |
| Cardiovascular disease | 13 (12.6) | 3 (4.3) | 0 (0) | 13 (9.2) | 10 (6.4) | 10 (6.8) |
| Respiratory disease | 10 (9.7) | 5 (7.2) | 0 (0) | 7 (4.9) | 12 (7.6) | 6 (4.1) |
| ChAdOx1 cohort (n = 448) | |||||
|---|---|---|---|---|---|
| ChAdOx1-S | Sputnik V C1 | Ad5-nCoV | BBIBP-CorV | mRNA-1273 | |
| Participants, n | 120 | 113 | 39 | 109 | 67 |
| Age, years, mean (SD) | 43 (11) | 41 (10) | 34 (8) | 40 (9) | 36 (20) |
| Gender, n (%) | |||||
| Female | 52 (43) | 52 (46) | 23 (59) | 52 (48) | 30 (45) |
| Male | 68 (57) | 61 (54) | 16 (41) | 57 (52) | 37 (55) |
| Comorbidities, n (%) | |||||
| Diabetes | 0 (0) | 2 (1.8) | 0 (0) | 2 (1.8) | 0 (0) |
| Obesity | 4 (3.3) | 6 (5.3) | 1 (2.6) | 8 (7.3) | 1 (1.5) |
| Cardiovascular disease | 3 (2.5) | 0 (0) | 0 (0) | 4 (3.7) | 0 (0) |
| Respiratory disease | 3 (2.5) | 6 (5.3) | 0 (0) | 6 (5.5) | 1 (1.5) |
| BBIBP-CorV cohort (n = 197) | ||||
|---|---|---|---|---|
| BBIBP-CorV | Sputnik V C1 | ChAdOx1-S | mRNA-1273 | |
| Participants, n | 41 | 77 | 37 | 42 |
| Age, years, mean (SD) | 36 (29) | 30 (12) | 25 (11) | 26 (11) |
| Gender, n (%) | ||||
| Female | 23 (56) | 40 (52) | 21 (57) | 21 (55) |
| Male | 18 (44) | 37 (48) | 16 (43) | 17 (45) |
| Comorbidities, n (%) | ||||
| Diabetes | 2 (4.9) | 1 (1.3) | 1 (2.7) | 0 (0) |
| Obesity | 0 (0) | 1 (1.3) | 0 (0) | 0 (0) |
| Cardiovascular disease | 2 (4.9) | 0 (0) | 3 (8.1) | 0 (0) |
| Respiratory disease | 0 (0) | 1 (1.3) | 0 (0) | 1 (2.6) |
Data are n (%) and mean (SD). n, number of volunteers; SD, standard deviation; C1, component 1; C2, component 2.